肾造瘻装置市场规模、份额及成长分析（按产品、最终用户及地区划分）－2026-2033年产业预测

全球肾造瘻装置市场规模预计在 2024 年达到 14.1 亿美元，从 2025 年的 15.3 亿美元成长到 2033 年的 29.6 亿美元，在预测期（2026-2033 年）内复合年增长率为 8.6%。

全球肾造瘻装置市场正经历强劲成长，这主要得益于肾臟疾病（例如尿道结石）发病率的不断上升，这些疾病影响着相当一部分人口，以及人们对微创手术方案的认识和需求日​​益增长。肾臟疾病（包括癌症）的普遍存在使得肾造瘻装置的使用成为必要，尤其是在尿路阻塞患者身上。此外，微创手术的优势，例如恢復时间短、併发症少、美观效果好，也促使人们在外科手术中越来越倾向于选择这些装置。然而，来自其他治疗方法的竞争以及肾造瘻手术本身固有的风险等潜在挑战可能会影响市场成长趋势，因此需要相关人员认真考虑。

全球肾造瘻管器械市场驱动因素

全球肾造瘻器械市场的主要驱动力是肾造瘻技术的显着进步。这些进步包括：开发出更优质的导管材料、改良的影像技术以实现精准的手术引导，以及创新的引流系统，从而提升肾造瘻手术的整体有效性和安全性。随着医疗机构不断寻求采用尖端高效的解决方案，这些技术进步在推动市场扩张方面发挥关键作用。器械设计和功能的持续改进不仅改善了患者的治疗效果，也鼓励医疗专业人员在临床实践中采用这些先进工具，最终推动市场向前发展。

限制全球肾造瘻管器械市场的因素

肾造瘻装置市场面临许多限制因素，主要原因在于这些产品的高成本。这些成本不仅包括装置本身，还包括有效使用所需的耗材和配件。这种经济负担会阻碍装置的普及，尤其是在预算紧张的医疗环境中，也会对经济困难的病人造成挑战。因此，肾造瘻装置的成本效益可能成为其广泛应用的障碍，并影响某些地区和医疗机构中患者获得这些重要医疗设备的机会。

全球肾造瘻装置市场趋势

由于安全性和便利性更高，全球肾造瘻装置市场正经历着向一次性肾造瘻装置的显着转变。随着医疗机构将病患安全放在首位，这些一次性装置的使用率不断提高，显着降低了交叉感染的风险。此外，它们无需再进行处理和消毒，使其成为医疗机构更有效率的选择。随着对感染控制和以患者为中心的护理的日益重视，这种对一次性装置的偏好预计将影响市场动态，并推动创新和投资，以研发符合不断发展的医疗保健标准的先进肾造瘘解决方案。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 案例研究
• 技术进步

全球肾造瘻装置市场规模（依产品及复合年增长率划分）（2026-2033 年）

• 导管导引线
• 引流管
• 肾造瘻管
• 鞘套扩张器
• 其他的

全球肾造瘻装置市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 急诊诊所
• 门诊手术中心（ASC）
• 其他的

全球肾造瘻装置市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Boston Scientific Corporation（United States）
• Teleflex Incorporated（United States）
• Becton, Dickinson and Company（United States）
• B. Braun SE（Germany）
• Cook Medical Incorporated（United States）
• Coloplast Group（Denmark）
• Olympus Corporation（Japan）
• Medtronic plc（Ireland）
• AngioDynamics Inc.（United States）
• Envaste Limited（United Kingdom）
• Medi-Globe GmbH（Germany）
• UROMED Kurt Drews KG（Germany）
• ROCAMED（France）
• Amecath（Egypt）
• SURGIMEDIK（India）
• Well Lead Medical Co., Ltd.（China）
• TROGE MEDICAL GmbH（Germany）
• Porges SA（France）
• Allium Medical Solutions Ltd.（Israel）

结论与建议

Global Nephrostomy Device Market size was valued at USD 1.41 Billion in 2024 and is poised to grow from USD 1.53 Billion in 2025 to USD 2.96 Billion by 2033, growing at a CAGR of 8.6% during the forecast period (2026-2033).

The global nephrostomy device market is experiencing robust growth, driven by increasing incidences of kidney disorders like urolithiasis, which affects a significant portion of the population, alongside rising awareness and the demand for minimally invasive surgical options. The prevalence of kidney diseases, including cancer, necessitates the use of nephrostomy devices, especially in patients facing urinary blockages. Furthermore, the advantages of minimally invasive surgery, such as shorter recovery times, reduced complications, and enhanced cosmetic results, are contributing to the rising preference for these devices in surgical procedures. However, potential challenges, including competition from alternative treatments and inherent risks associated with nephrostomy procedures, could impact growth dynamics, warranting careful consideration by stakeholders within the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nephrostomy Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nephrostomy Device Market Segments Analysis

Global Nephrostomy Device Market is segmented by Product, End User and region. Based on Product, the market is segmented into Guidewires, Drainage Tubes, Nephrostomy Catheters, Sheath Dilators and Others. Based on End User, the market is segmented into Hospital, Emergency Clinics, Ambulatory Surgical Centers (ASCs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nephrostomy Device Market

The Global Nephrostomy Device market is primarily driven by significant advancements in nephrostomy technology, including the development of superior catheter materials, enhanced imaging methods for precise procedural guidance, and innovative drainage systems that improve the overall effectiveness and safety of nephrostomy procedures. As healthcare providers continuously strive to adopt cutting-edge and efficient solutions, these technological improvements play a crucial role in fostering market expansion. The ongoing evolution in device design and functionality not only enhances patient outcomes but also encourages medical professionals to implement these advanced tools within clinical settings, ultimately propelling the market forward.

Restraints in the Global Nephrostomy Device Market

The nephrostomy device market faces significant constraints primarily due to the elevated costs associated with these products. This expense encompasses not only the devices but also the necessary consumables and accessories needed for effective use. Such financial implications can hinder adoption in various healthcare environments, particularly those with tighter budgets, and can present challenges for patients who are experiencing financial difficulties. As a result, the affordability of nephrostomy devices poses a barrier to their widespread utilization, potentially impacting patient access to these important medical tools in certain regions and healthcare settings.

Market Trends of the Global Nephrostomy Device Market

The Global Nephrostomy Device market is witnessing a notable shift towards disposable nephrostomy devices, driven by their enhanced safety features and convenience. Healthcare providers are prioritizing patient safety, leading to increased adoption of these single-use devices that significantly reduce the risk of cross-contamination and infection. Additionally, the elimination of reprocessing and sterilization requirements makes them a more efficient option for healthcare facilities. As the emphasis on infection control and patient-centric care grows, this preference for disposable devices is anticipated to shape market dynamics, encouraging innovations and investments in advanced nephrostomy solutions tailored to meet evolving healthcare standards.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Nephrostomy Device Market Size by Product & CAGR (2026-2033)

• Market Overview
• Guidewires
• Drainage Tubes
• Nephrostomy Catheters
• Sheath Dilators
• Others

Global Nephrostomy Device Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospital
• Emergency Clinics
• Ambulatory Surgical Centers (ASCs)
• Others

Global Nephrostomy Device Market Size & CAGR (2026-2033)

• North America (Product, End User)
  • US
  • Canada
• Europe (Product, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coloplast Group (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Envaste Limited (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medi-Globe GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UROMED Kurt Drews KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ROCAMED (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amecath (Egypt)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SURGIMEDIK (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Well Lead Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TROGE MEDICAL GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Porges SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allium Medical Solutions Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations